This study is looking at how well a product called **QUTENZA** works for people with painful diabetic peripheral neuropathy (PDPN). **Diabetic Peripheral Neuropathy** is a nerve problem that happens when diabetes affects the nerves, especially in the feet. **QUTENZA** is a patch used to help reduce nerve pain.
The study will collect real-world information to see if using QUTENZA repeatedly helps to reduce pain and the use of other pain medicines. People between the ages of 18 and 80 with a confirmed diagnosis of PDPN can participate. To join, you must not have other pain conditions that confuse the study, and you should not have tried QUTENZA before.
**Important things to know about this study:**
- **Participation Length:** The study does not specify the exact length, but you must agree not to join other studies during this time.
- **Eligibility:** You need a stable medication routine for PDPN for at least 4 weeks before starting.
- **Risks:** If you have allergies to capsaicin or certain skin conditions, you cannot participate.
To be a part of the study, you must agree to follow the study rules and visit the clinic for assessments.
How understandable was the trial content above?
Hard to understand
Easy to understand